Yoshiaki Usui

Aug 2, 2023 | onlinelibrary.wiley.com | Yukihide Momozawa |Yoshiaki Usui

3.3 Optimization of target individuals benefit from genetic testing In the United States Consensus Conference, germline testing has been expanding for metastatic prostate cancer or for all patients with a personal history of breast cancer.65, 66 These expansions might be extended to individuals unaffected by the disease.